Siemens Healthineers CEO: We could sell diagnostics division by 2030

Siemens Healthineers has yet to speak with any potential buyers but is considering spinning off or divesting its diagnostics division after restructuring it by 2030.

The CEO Bernd Montag said that it was possible that the Diagnostics Business would no longer be a part of the Medical Technology Group in 2030, if this is deemed to be better for the Division. This was stated at a Monday press conference on the sidelines its Capital Markets Day.

Healthineers targets a 6-9% annual revenue increase from its two other divisions, Imaging and Precision Therapy. The diagnostics arm will see growth of mid-single digits.

Jochen Schmitz, finance chief at Siemens, stated that the annual U.S. Tariffs burden of around 400 million euros (464 million dollars) will be completely offset by 2028 due to increased productivity and prices. Parent Siemens announced last week it would reduce its 33.5 billion euros stake in Healthineers through a transfer of shares to its shareholders.

Siemens will focus on automation for buildings and factories, as well as trains.

Siemens added that it could reduce its stake to less than 20 percent in the medium-term.

(source: Reuters)